Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

21 May 2009

Microvasculopathy does not predict coronary artery disease of the transplanted heart

M Zakliczyński, J Nożyński, D Konecka-Mrówka, Ł Pyka, D Trybunia, A Lekston, M Świerad, R Przybylski, M Zembala

Ann Transplant 2009; 14(1): 65-66 :: ID: 880439

Abstract

Background: A relation between microvasculopathy observed in endomyocardial biopsies (EMBs) and clinical coronary vasculopathy (CAV) after orthotopic heart transplantation (OHT) remains controversial. Aim of the study was to find a potential relation between microvasculopathy features in late EMBs and clinically confirmed CAV in long-term OHT survivors.
Material/Methods: We performed a retrospective analysis involving 68 pts. in
whom OHT was performed before 1999 - CAV (+) group consisted of 37 pts.
(35M/2F, 45±11y/o, ischemic c-pathy in 57%) with established CAV (need for coronary angioplasty, myocardial infarction or CAV-related death), control group was composed of 31 pts. (24M/7F, 43±16y/o, ischemic c-pathy in 39%) with negative coronary angiography 10 years after OHT. Microvasculopathy was assessed in elective EMBs performed 12 and 36 months after OHT using the following features: presence of prominent endothelial cells, degeneration of the endothelium, thickening of the muscle layer, thickening of the basal membrane, presence of lymphocytes in the arteriolar wall without any other signs of rejection vasculitis, periarteriolar fibrosis, and an occluded arteriolar lumen. Rejection grades in analyzed EMBs were comparable in both groups.
Results: The only significant difference was observed in occurrence of thickening of the basal membrane which was present in 22% of pts. from CMV (+) group and 3% of individuals from the control group. All other features, both in 12 and 36 month EMB, were similarly distributed (including basal membrane thickening 36 months after OHT).
Conclusions: Microvasculopathy observed 12 and 36 months after OHT is not predictive for CAV development.

Keywords: Heart Transplantation

Comments

In Press

06 May 2022 : Original article  

Phosphatidylethanol (PEth) for Monitoring Sobriety in Liver Transplant Candidates: Preliminary Results of D...

Ann Transplant In Press; DOI: 10.12659/AOT.936293  

27 Apr 2022 : Review article  

A Systematic Review of the Literature on Chronic Kidney Disease Following Liver Transplantation

Ann Transplant In Press; DOI: 10.12659/AOT.935170  

Most Viewed Current Articles

29 Dec 2021 : Original article  

Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...

DOI :10.12659/AOT.933588

Ann Transplant 2021; 26:e933588

26 Jan 2022 : Review article  

Recurrence of Hepatocellular Carcinoma After Liver Transplantation: Risk Factors and Predictive Models

DOI :10.12659/AOT.934924

Ann Transplant 2022; 27:e934924

24 Jul 2020 : Review article  

Kidney Transplantation in the Times of COVID-19 – A Literature Review

DOI :10.12659/AOT.925755

Ann Transplant 2020; 25:e925755

15 Mar 2022 : Case report  

Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...

DOI :10.12659/AOT.935860

Ann Transplant 2022; 27:e935860

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358